Rocket Lab USA, Inc. (NASDAQ: RKLB) saw its shares skyrocket 19.86% in Friday premarket trading after the U.S. commercial aerospace firm delivered a blockbuster first-quarter 2026 earnings report that handily crushed analyst expectations, cementing its status as one of the most closely watched growth plays in the global capital markets.
Rocket Lab reported total revenue of $200.3 million for the first quarter, representing a 63.5% year-over-year surge that far exceeded Wall Street’s sales forecasts. The company also notched a record-high GAAP gross profit margin of 38.2%, marking a better-than-expected improvement in its profitability profile.
The standout earnings performance was backed by a historic surge in contract wins, which laid a solid foundation for sustained top-line growth ahead. In the first quarter of 2026 alone, Rocket Lab signed more launch contracts than it did in the full year of 2025, adding 31 Electron rocket missions to its backlog and securing a new contract for five launches of its next-generation Neutron rocket. The Neutron rocket, designed to carry 13 to 15 tons of cargo to Low Earth Orbit, can deliver 40 times the payload of the Electron rocket, positioning it to go head-to-head with SpaceX and fill a gap in the commercial medium-to-heavy reusable rocket market.
Beyond its core space launch business, Rocket Lab is unlocking secondary growth engines through strategic business expansion. In deep space exploration, the company launched its new Gauss electric thruster, which enables more efficient in-orbit maneuvering for satellites and can power spacecraft on interplanetary missions. In the national security space sector, the company partnered with RTX Corporation to win a spot on the U.S. Space Force’s Space-Based Interceptor missile defense program, breaking into the high-barrier defense aerospace market.
Riding the strong growth momentum, the company issued an upbeat revenue guidance for the ongoing second quarter of 2026, projecting revenue as high as $240 million, which would translate to a year-over-year growth rate of up to 66% — an acceleration from its already impressive Q1 performance.
As the second-largest player in the global commercial space industry behind SpaceX, Rocket Lab holds a $45 billion market valuation and is widely regarded as a top-tier pure-play opportunity for retail investors looking to gain exposure to the burgeoning space economy. Its core investment appeal stems from its unique scarcity in the market: SpaceX remains privately held, while aerospace giants like Boeing and Lockheed Martin have diversified business portfolios beyond space, including defense weaponry segments that may not align with space-focused investors’ priorities. Rocket Lab, by contrast, is one of the few publicly traded pure-play space companies with steady revenue streams, frequently referred to as a “young SpaceX” by market participants.
The stock has long been a standout performer in the aerospace sector. Since its public debut in November 2020, Rocket Lab’s share price has rallied nearly 706%, and it has gained close to 13% year-to-date in 2026, demonstrating remarkable resilience and upward momentum amid heightened volatility in the global equity markets.
Wall Street analysts have grown increasingly bullish on the stock. In May alone, 17 analyst ratings were issued on RKLB, with over 70% being “Strong Buy” or “Buy” recommendations, and only 5 “Hold” ratings. The consensus 12-month price target from Wall Street stands at $87.56, representing meaningful upside from the stock’s $78.58 closing price on May 7, 2026. Even CoinCodex, a technical trading platform known for its conservative price forecasts, projects an average annualized price of $97.84 for RKLB in 2026, and sees the stock reaching $311.37 in 2030 if it maintains its current strong growth trajectory.
Looking further ahead, consensus market estimates project Rocket Lab’s revenue could grow 10-fold over the next decade, surpassing $8.8 billion in 2035, with earnings per share approaching $7 that year, pointing to a vastly expanded long-term growth ceiling.
Investors should also note the associated risks with the stock. Rocket Lab remains unprofitable, posting a net loss of $183 million over the past 12 months and negative free cash flow of more than $315 million. Even with $680 million in trailing 12-month revenue, its $45 billion market capitalization gives it a price-to-sales ratio of 67, which sits in a relatively high valuation range. Market participants are advised to balance the market hype with fundamental realities and manage their investment pace prudently.
